Literature DB >> 10051126

Transcriptional down-regulation of the rabbit pulmonary artery endothelin B receptor during phenotypic modulation.

R Owe-Young1, C G Schyvens, R A Qasabian, A D Conigrave, P S Macdonald, D J Williamson.   

Abstract

1. We confirmed that endothelium-independent contraction of the rabbit pulmonary artery (RPA) is mediated through both an endothelin A (ET(A)R) and endothelin B (ET(B2)R) receptor. 2. The response of endothelium-denuded RPA rings to endothelin-1 (ET-1, pD2 = 7.84 +/- 0.03) was only partially inhibited by BQ123 (10 microM), an ET(A)R antagonist. 3. Pretreatment with 1 nM sarafotoxin S6c (S6c), an ET(B)R agonist, desensitized the ET(B2)R and significantly attenuated the response to ET-3 (pD2 = 7.40 +/- 0.02 before, <6.50 after S6c). 4. Pretreatment with S6c had little effect on the response to ET-1, but BQ123 (10 microM) caused a parallel shift to the right of the residual ETAR-mediated response to ET-1 (pD2 = 7.84 +/- 0.03 before S6c, 7.93 +/- 0.03 after S6c, 6.81 +/- 0.05 after BQ123). 5. Binding of radiolabelled ET-1 to early passage cultures of RPA vascular smooth muscle cells (VSMC) displayed two patterns of competitive displacement characteristic of the ET(A)R (BQ123 pIC50 = 8.73 +/- 0.05) or ET(B2)R (S6c pIC50 = 10.15). 6. Competitive displacement experiments using membranes from late passage VSMC confirmed only the presence of the ET(A)R (ET-1 pIC50 = 9.3, BQ123 pIC50 = 8.0, S6c pIC50 < 6.0). 7. The ET(A)R was functionally active and coupled to rises in intracellular calcium which exhibited prolonged homologous desensitization. 8. Using a reverse transcriptase polymerase chain reaction for the rabbit ET(B2)R, we demonstrated the absence of mRNA expression in phenotypically modified VSMC. 9. We conclude that the ET(B2)R expressed by VSMC which mediates contraction of RPA is rapidly down-regulated at the transcriptional level during phenotypic modulation in vitro.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10051126      PMCID: PMC1565786          DOI: 10.1038/sj.bjp.0702280

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

1.  Importance of the phenotypic state of vascular smooth muscle cells on the binding and the mitogenic activity of endothelin.

Authors:  C Serradeil-Le Gal; J M Herbert; C Garcia; M Boutin; J P Maffrand
Journal:  Peptides       Date:  1991 May-Jun       Impact factor: 3.750

Review 2.  Arterial smooth muscle. A multifunctional mesenchymal cell.

Authors:  G R Campbell; J H Campbell; J A Manderson; S Horrigan; R E Rennick
Journal:  Arch Pathol Lab Med       Date:  1988-10       Impact factor: 5.534

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Characterization of galanin receptors in the insulin-secreting cell line Rin m 5F: evidence for coupling with a pertussis toxin-sensitive guanosine triphosphate regulatory protein.

Authors:  I Lagny-Pourmir; B Amiranoff; A M Lorinet; K Tatemoto; M Laburthe
Journal:  Endocrinology       Date:  1989-05       Impact factor: 4.736

5.  Pharmacological characterization of the nucleotide receptors that mobilize Ca2+ ions in human parathyroid cells.

Authors:  C A Gibb; D I Cook; L Delbridge; A D Conigrave
Journal:  J Endocrinol       Date:  1994-08       Impact factor: 4.286

6.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

7.  Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788.

Authors:  K Ishikawa; M Ihara; K Noguchi; T Mase; N Mino; T Saeki; T Fukuroda; T Fukami; S Ozaki; T Nagase
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

8.  Endothelin receptor subtypes in human versus rabbit pulmonary arteries.

Authors:  T Fukuroda; M Kobayashi; S Ozaki; M Yano; T Miyauchi; M Onizuka; Y Sugishita; K Goto; M Nishikibe
Journal:  J Appl Physiol (1985)       Date:  1994-05

9.  Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?

Authors:  D J Stewart; R D Levy; P Cernacek; D Langleben
Journal:  Ann Intern Med       Date:  1991-03-15       Impact factor: 25.391

10.  Subtypes of endothelin ETA and ETB receptors mediating venous smooth muscle contraction.

Authors:  S A Sudjarwo; M Hori; T Tanaka; Y Matsuda; T Okada; H Karaki
Journal:  Biochem Biophys Res Commun       Date:  1994-04-15       Impact factor: 3.575

View more
  3 in total

Review 1.  An overview of potential molecular mechanisms involved in VSMC phenotypic modulation.

Authors:  Ming-Jie Zhang; Yi Zhou; Lei Chen; Yan-Qin Wang; Xu Wang; Yan Pi; Chang-Yue Gao; Jing-Cheng Li; Li-Li Zhang
Journal:  Histochem Cell Biol       Date:  2015-12-26       Impact factor: 4.304

2.  Localization and function of ET-1 and ET receptors in small arteries post-myocardial infarction: upregulation of smooth muscle ET(B) receptors that modulate contraction.

Authors:  G A Gray; E J Mickley; D J Webb; P E McEwan
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

3.  Regional modulation of cyclic nucleotides by endothelin-1 in rat pulmonary arteries: direct activation of G(i)2-protein in the main pulmonary artery.

Authors:  I Mullaney; D M Vaughan; M R MacLean
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.